Volume 15 (2020)
Volume 14 (2019)
Volume 13 (2018)
Volume 12 (2017)
Volume 11 (2016)
Volume 10 (2015)
Volume 9 (2014)
Volume 8 (2013)
Volume 7 (2012)
Volume 6 (2011)
Volume 5 (2010)
Volume 4 (2009)
Volume 3 (2008)
Volume 2 (2007)
Volume 1 (2006)
Endocrine Pathology
1. Promoter Methylation of Four Tumor Suppressor Genes in Human Papillary Thyroid Carcinoma

Fatemeh Khatami; Bagher Larijani; Ramin Heshmat; Shirzad Nasiri; Hiva Saffar; Gita Shafiee; Azam Mossafa; Seyed Mohammad Tavangar

Volume 14, Issue 4 , Autumn 2019, , Pages 290-298

http://dx.doi.org/10.30699/ijp.2019.94401.1922

Abstract
  Background & Objective: Papillary thyroid cancer (PTC) is considered to be the most common type of thyroid malignancies. Epigenetic alteration, in which the chromatin conformation and gene expression change without changing the sequence of DNA, can occur in some tumor suppressor genes and oncogenes. ...  Read More

Nephropathology
2. Dyspnea as the First Manifestation of Silent Renal Cell Carcinoma

Atieh Khorsand-Rahimzadeh; Fatemeh Khatami; Salma Sefidbakht; Hiva Saffar; Seyed Mohammad Tavangar

Volume 14, Issue 1 , Winter 2019, , Pages 87-93

http://dx.doi.org/10.30699/ijp.14.1.87

Abstract
  Renal cell carcinoma (RCC) accounts for only 3% of adult malignancies, and the lung is the most common site of metastasis of this tumor, which may be accompanied by pleural metastasis. However, solitary pleural involvement is very rare and its presentation with dyspnea as the first manifestation of RCC ...  Read More

Biology & Genetic
3. A Review of Driver Genetic Alterations in Thyroid Cancers

Fatemeh Khatami; Mohammad Tavangar

Volume 13, Issue 2 , Spring 2018, , Pages 125-135

http://dx.doi.org/10.30699/ijp.13.2.125

Abstract
  Thyroid cancer is a frequent endocrine related malignancy with continuous increasing incidence. There has been moving development in understanding its molecular pathogenesis recently mainly through the explanation of the original role of several key signaling pathways and related molecular distributors. ...  Read More

Endocrine Pathology
4. Current Diagnostic Status of Pheochromocytomaand Future Perspective: A Mini Review

Fatemeh Khatami; Seyed Mohammad Tavangar

Volume 12, Issue 3 , Summer 2017, , Pages 313-322

Abstract
  Pheochromocytomas (PCCs) are rare neuroendocrine tumors. The current diagnostic tools are based on biochemistry and histopathology results, but heterogeneity of diagnostic markers, signs and symptoms of PCCs bring a lot of difficulties for these two current methods. Unfortunately microscopic understanding ...  Read More